Hip implant registry reveals how long replacements last
NCT ID NCT02520544
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 472 adults aged 18-75 who received a specific type of hip replacement to see how long the implants lasted. Researchers used patient surveys and survival curves to measure device performance. The goal was to gather long-term data, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
472 people
The number who actually took part.
- Start date
-
Jan 2012
- Finished
-
Nov 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Male and non-pregnant female patients between 18-75 years of age. 2. Patients requiring uncemented primary Total Hip Arthroplasty (THA), suitable for the use of the Accolade stem and Trident/Tritanium cup. 3. Patients with a diagnosis of osteoarthritis (OA). 4. Patients who understand the conditions of the study and are willing and able to comply with the post-operative scheduled clinical and radiographic evaluations and the prescribed rehabilitation. 5. Patients who signed the Ethics Committee approved Informed Consent Form prior to surgery. Exclusion Criteria: 1. Patients who require revision of a previously implanted hip prosthesis. 2. Patients who had a THA on contralateral side within the last 6 months. 3. Patients who had a THA on contralateral side more than 6 months ago and the rehabilitation period outcome was considered unsatisfactory or not good (Harris Hip Score \< 85). 4. Patients who will need lower limb joint replacement for another joint within one year. 5. Patients requiring bilateral hip replacement. 6. Patients who have had a prior procedure of acetabular osteotomy. 7. Patients with acute femoral fractures 8. Obese patients where obesity is severe enough to affect subject's ability to perform activities of daily living (body mass index, kg/m2: BMI ≥ 35). 9. Patients with active or suspected infection. 10. Patients with malignancy - active malignancy. 11. Patients with severe osteoporosis, rheumatoid arthritis (RA), Paget's disease or renal osteodystrophy. 12. Patients immunologically suppressed, or receiving steroids in excess of physiologic dose requirements. 13. The patient has a neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device or the patient has a neurological deficit which interferes with the patient's ability to limit weight bearing or places an extreme load on the implant during the healing period. 14. Female patients planning a pregnancy during the course of the study. 15. Patients with systemic or metabolic disorders leading to progressive bone deterioration. 16. Patients, who as judged by the surgeon, are mentally incompetent or are unlikely to be compliant with the prescribed post-operative routine and follow-up evaluation schedule. 17. Patients with other severe concurrent joint involvements, which can affect their outcome. 18. Patients with other concurrent illnesses, which are likely to affect their outcome such as sickle cell anaemia, systemic lupus erythematosus or renal disease requiring dialysis. 19. Patient with a known sensitivity to device materials. 20. Patients under the protection of law (e.g. guardianship).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthroplasty, replacement, hip are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amphia Ziekenhuis
Breda, Netherlands
-
Harrogate and District NHS Foundation Trust
Harrogate, United Kingdom
-
Maatschap Orthopaedie Ikazia
Rotterdam, Netherlands
-
Orbis Medisch Concern
Sittard, Netherlands
-
Rijnstate Arnhem
Zevenaar, Netherlands
-
Skånevård Kryh Division Kirurgi och Ortopedkliniken Hässleholm
Hässleholm, Sweden
-
St. Antonius Ziekenhuis
Nieuwegein, Utrecht, Netherlands
-
Ziekenhuis Netwerk Antwerpen
Antwerp, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- Surgeons test augmented reality to Fine-Tune knee replacement cuts
- Can a purified form of ibuprofen better tame osteoarthritis pain?
- Could simple home exercises be the key to better knee health?
- Can a new plastic hip liner outlast the old ones?
- Which injection eases arm pain better: steroid or Anti-Inflammatory?